Stem Cell Research & Therapy

Table 6 The results of node-splitting method for ONFH progression

From: Regenerative therapies for femoral head necrosis in the past two decades: a systematic review and network meta-analysis

Comparison	ONFH progression		P value
CD vs. ABG	Direct	2.7 (0.13, 5.9)	0.37
CD vs. ABG	Indirect	2.2 (0.3, 3.0)	0.37
FVBG vs. ABG	Direct	1.0 (0.09, 8.9)	0.37
FVBG vs. ABG	Indirect	0.1 (0.01, 14)	0.37
MSCs vs. BMAC	Direct	0.3 (0.01, 9.2)	0.88
MSCs vs. BMAC	Indirect	0.4 (0.01, 23)	0.88
CD vs. BMAC	Direct	4.0 (1.3, 19)	0.89
CD vs. BMAC	Indirect	2.9 (0.02, 4.2)	0.89
CD vs. MSCs	Direct	9.1 (0.26, 46)	0.88
CD vs. MSCs	Indirect	13 (0.39, 61)	0.88
FVBG vs CD	Direct	0.04 (0.01, 1.6)	0.36
FVBG vs CD	Indirect	0.36 (0.01, 1.5)	0.36

ABG autologous bone grafting, BMAC bone marrow aspirate concentration, CD core decompression, FVBG free vascular vascularized bone grafting, MSCs mesenchymal stem cells, MSCs mesenchymal stem cells, ONFH osteonecrosis of the femoral head

Back to article page

ISSN: 1757-6512

Contact us

Submission enquiries: Access here and click Contact Us
General enquiries: info@biomedcentral.com